iodoazomycin arabinoside has been researched along with Diabetes Mellitus, Type 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Arafaj, A; Hutchison, K; Mannan, RH; McEwan, AJ; Mercer, J; Ryan, EA; Wiebe, LI | 1 |
1 other study(ies) available for iodoazomycin arabinoside and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Gas Monitoring, Transcutaneous; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Foot; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Nitroimidazoles; Peripheral Vascular Diseases; Radionuclide Imaging | 1994 |